跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,200 条关于
“Thrive Global”
全部
19,200
临床试验
6,721
药物
90
机构
231
资讯
12,158
14天前
Biological Age and Longevity Diagnostics Market Projected to Reach $5.58 Billion by 2030
3个月前
St. Jude Redesignated as WHO Collaborating Centre for Childhood Cancer, Expanding Global Pediatric Oncology Efforts
去年
Israeli Healthtech Innovation Drives Global Healthcare Solutions
6个月前
Sentynl Therapeutics Licenses Progerinin for Hutchinson-Gilford Progeria Syndrome Treatment
2年前
Viridian Therapeutics' Veligrotug Shows Promise in Phase III Thyroid Eye Disease Trial
去年
Viridian's Veligrotug Shows Promise in Phase 3 Trial for Chronic Thyroid Eye Disease
去年
First-of-its-kind Gene Editing Treatment Saves Baby with Rare Genetic Disorder
2个月前
ARPA-H Launches $160 Million THRIVE Program to Advance Custom Gene Editing for Rare Diseases
上个月
Elevar Therapeutics to Present Three Abstracts at ESMO 2026, Including Phase 2 THRIVE Trial of Rivoceranib in Thymic Tumors
2个月前
ARPA-H THRIVE Awards $73.4 Million to Advance Personalized Gene-Editing Platforms for Rare Pediatric Diseases
第 1 页,共 1216 页
上一页
下一页